Lea Zila
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lea Zila has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Dmitriy Sheyn
Orthopaedic Stem Cell Research Laboratory, Cedars-Sinai Medical Center
2 shared publications Jacob T. Wechsler
Orthopaedic Stem Cell Research Laboratory, Cedars-Sinai Medical Center, Los Angeles, California, USA
2 shared publicationsAleksander Stotland
Orthopaedic Stem Cell Research Laboratory, Cedars-Sinai Medical Center, Los Angeles, California, USA
1 shared publicationAlexander Tuchman
Department of Orthopaedics, Cedars-Sinai Medical Center, Los Angeles, USA
1 shared publicationBegonya Comin-Anduix
Department of Surgery, University of California, Los Angeles, California, USA
1 shared publicationBert Mandelbaum
Department of Orthopaedics, Cedars-Sinai Medical Center, Los Angeles, California, USA
1 shared publication
Latest Publications
- Open Access
- 19 May 2026
- Published by SAGE Publications in Orthopaedic Journal of Sports Medicine
- Vol. 14 (5)
Immune Cell Composition and Protein Biomarkers Correlate With PRP Treatment Outcomes in Knee Osteoarthritis
Background: Current treatments for osteoarthritis (OA) include physical therapy, nonsteroidal anti-inflammatory drugs, and joint arthroplasty, which aim to address symptoms rather than modify disease progression. Autologous platelet-rich plasma (PRP) and other biologics administered in the affected joint are widely used as alternatives that are believed to alleviate symptoms. However, PRP's effectiveness in reducing knee OA pain is inconsistent across the literature, and the specific therapeutic components remain unclear. Purpose: To identify whether specific cellular and protein biomarkers correlate with patient-reported outcomes and can therefore serve as predictive biomarkers for PRP effectiveness. Study Design: Case series; Level of evidence, 4. Methods: PRP samples from 30 patients (30 knees) with knee OA (Kellgren & Lawrence grades 2-3) who were undergoing PRP treatment were analyzed to identify biomarkers associated with response. Blood samples were drawn, and 2 identical PRP samples were prepared, with one set used for therapy and the other for analysis. Component analysis included cell counts, immune cell, and platelet characterization via mass cytometry, along with proteomic analysis using mass spectrometry. Clinical outcomes were assessed using the Knee injury and Osteoarthritis Outcome Score (KOOS) and Patient-Reported Outcomes Measurement Information System patient reported outcomes at baseline and up to 6 months postinjection. Results: PRP therapy improved pain in 19 of 30 patients at 6 weeks postinjection (mean ± SD age, 56.04 ± 10.56 years): Several distinct immune cell clusters (T helper 1 CD4 T cells ( r = 0.44; P < .05), Central memory CD4 T cells ( r = 0.46; P < .05), Effector memory CD4 T cells ( r = 0.52; P < .05), and CD8 T cells ( r = 0.44; P < .05) positively correlated with ΔKOOS ( P < .05). Proteomic analysis showed that differentially expressed proteins integrin-linked kinase ( r = −0.50; P < .05), and glutathione peroxidase 1 ( r = −0.55; P < .01) negatively correlated with ΔKOOS Pain ( P < .05), whereas cathepsin G ( r = 0.51; P < .05), and calprotectin subunit ( r = 0.65; P < .01) were positively correlated with ΔKOOS Pain ( P < .05) (* P < .05, ** P < 0.01). Conclusion: These findings suggest that some cellular and protein biomarkers may potentially be used as therapeutic targets and predictive markers for PRP success, guiding personalized therapeutic strategies. However, these targets must be further validated for knee OA in future studies.
- 19 May 2026
- Published by SAGE Publications in Orthopaedic Journal of Sports Medicine
- Vol. 14 (5)
Open AccessImmune Cell Composition and Protein Biomarkers Correlate With PRP Treatment Outcomes in Knee Osteoarthritis
Background: Current treatments for osteoarthritis (OA) include physical therapy, nonsteroidal anti-inflammatory drugs, and joint arthroplasty, which aim to address symptoms rather than modify disease progression. Autologous platelet-rich plasma (PRP) and other biologics administered in the affected joint are widely used as alternatives that are believed to alleviate symptoms. However, PRP's effectiveness in reducing knee OA pain is inconsistent across the literature, and the specific therapeutic components remain unclear. Purpose: To identify whether specific cellular and protein biomarkers correlate with patient-reported outcomes and can therefore serve as predictive biomarkers for PRP effectiveness. Study Design: Case series; Level of evidence, 4. Methods: PRP samples from 30 patients (30 knees) with knee OA (Kellgren & Lawrence grades 2-3) who were undergoing PRP treatment were analyzed to identify biomarkers associated with response. Blood samples were drawn, and 2 identical PRP samples were prepared, with one set used for therapy and the other for analysis. Component analysis included cell counts, immune cell, and platelet characterization via mass cytometry, along with proteomic analysis using mass spectrometry. Clinical outcomes were assessed using the Knee injury and Osteoarthritis Outcome Score (KOOS) and Patient-Reported Outcomes Measurement Information System patient reported outcomes at baseline and up to 6 months postinjection. Results: PRP therapy improved pain in 19 of 30 patients at 6 weeks postinjection (mean ± SD age, 56.04 ± 10.56 years): Several distinct immune cell clusters (T helper 1 CD4 T cells ( r = 0.44; P < .05), Central memory CD4 T cells ( r = 0.46; P < .05), Effector memory CD4 T cells ( r = 0.52; P < .05), and CD8 T cells ( r = 0.44; P < .05) positively correlated with ΔKOOS ( P < .05). Proteomic analysis showed that differentially expressed proteins integrin-linked kinase ( r = −0.50; P < .05), and glutathione peroxidase 1 ( r = −0.55; P < .01) negatively correlated with ΔKOOS Pain ( P < .05), whereas cathepsin G ( r = 0.51; P < .05), and calprotectin subunit ( r = 0.65; P < .01) were positively correlated with ΔKOOS Pain ( P < .05) (* P < .05, ** P < 0.01). Conclusion: These findings suggest that some cellular and protein biomarkers may potentially be used as therapeutic targets and predictive markers for PRP success, guiding personalized therapeutic strategies. However, these targets must be further validated for knee OA in future studies.
- Open Access
- 9 March 2026
- Published by SAGE Publications in CARTILAGE
- Vol. 17 (4) , 928-938
Protective Effects of Spirulina Supplementation on Chondrocytes Under Moderate Acute Dynamic Compression
Objective: To determine the influence of Spirulina supplementation on the response of bovine chondrocytes to mechanical compression with respect to extracellular matrix dynamics (proteoglycan and collagen) and inflammation [nitric oxide (NO)]. Methods: Bovine chondrocytes were embedded in agarose constructs and cultured for 14 days in basal media or media supplemented with Spirulina (30 or 90 µg/mL). Constructs were exposed to 10% dynamic compression. DNA content, NO levels, proteoglycan content and release, and collagen synthesis were measured to assess extracellular matrix (ECM) responses. Results: DNA content did not differ among groups. Spirulina supplementation increased NO levels in constructs and media, with the highest effect observed at 90 µg/mL. Proteoglycan content decreased in Spirulina-treated constructs and declined further after compression, while proteoglycan release increased across all groups. Collagen synthesis and content were elevated by Spirulina, particularly at 90 µg/mL, and further increased following dynamic compression. Conclusions: Spirulina supplementation, particularly at higher concentrations, enhances ECM turnover and increases NO production in chondrocytes under mechanical loading, indicating potential modulation of matrix dynamics that may be beneficial. However, these results are derived from an in vitro model and may not fully represent in vivo physiological conditions.
- 9 March 2026
- Published by SAGE Publications in CARTILAGE
- Vol. 17 (4) , 928-938
Open AccessProtective Effects of Spirulina Supplementation on Chondrocytes Under Moderate Acute Dynamic Compression
Objective: To determine the influence of Spirulina supplementation on the response of bovine chondrocytes to mechanical compression with respect to extracellular matrix dynamics (proteoglycan and collagen) and inflammation [nitric oxide (NO)]. Methods: Bovine chondrocytes were embedded in agarose constructs and cultured for 14 days in basal media or media supplemented with Spirulina (30 or 90 µg/mL). Constructs were exposed to 10% dynamic compression. DNA content, NO levels, proteoglycan content and release, and collagen synthesis were measured to assess extracellular matrix (ECM) responses. Results: DNA content did not differ among groups. Spirulina supplementation increased NO levels in constructs and media, with the highest effect observed at 90 µg/mL. Proteoglycan content decreased in Spirulina-treated constructs and declined further after compression, while proteoglycan release increased across all groups. Collagen synthesis and content were elevated by Spirulina, particularly at 90 µg/mL, and further increased following dynamic compression. Conclusions: Spirulina supplementation, particularly at higher concentrations, enhances ECM turnover and increases NO production in chondrocytes under mechanical loading, indicating potential modulation of matrix dynamics that may be beneficial. However, these results are derived from an in vitro model and may not fully represent in vivo physiological conditions.
- Top Cited PapersOpen Access
- 21 October 2025
- Published by Springer Nature in Bone Research
- Vol. 13 (1) , 1-28
What a pain in the back: etiology, diagnosis and future treatment directions for discogenic low back pain
Chronic lower back pain (LBP) is the leading cause of disability worldwide. Due to its close relationship with intervertebral disc (IVD) degeneration (IVDD), research has historically focused more on understanding the mechanism behind IVDD while clinical efforts prioritize pain management. More recently, there has been a shift toward understanding LBP as a distinct pathological entity. This review synthesizes current knowledge on discogenic LBP, combining known pathophysiology, molecular mechanisms, risk factors, diagnostic challenges, and available experimental models. IVDD is a complex, multifactorial process involving biochemical, mechanical, and inflammatory changes within the disc, leading to structural breakdown and potential discogenic pain. Key mechanisms include extracellular matrix degradation, upregulation of inflammatory mediators, immune cell infiltration, and aberrant nerve and vascular ingrowth. However, not all cases of IVDD result in LBP, highlighting the need for further investigation into the cellular, molecular, and biomechanical factors contributing to symptom development. Current diagnostic tools and experimental models for studying discogenic LBP remain limited, impeding the development of targeted treatments. Existing therapies primarily focus on symptom management rather than addressing underlying disease mechanisms.
- 21 October 2025
- Published by Springer Nature in Bone Research
- Vol. 13 (1) , 1-28
Top Cited PapersOpen AccessWhat a pain in the back: etiology, diagnosis and future treatment directions for discogenic low back pain
Chronic lower back pain (LBP) is the leading cause of disability worldwide. Due to its close relationship with intervertebral disc (IVD) degeneration (IVDD), research has historically focused more on understanding the mechanism behind IVDD while clinical efforts prioritize pain management. More recently, there has been a shift toward understanding LBP as a distinct pathological entity. This review synthesizes current knowledge on discogenic LBP, combining known pathophysiology, molecular mechanisms, risk factors, diagnostic challenges, and available experimental models. IVDD is a complex, multifactorial process involving biochemical, mechanical, and inflammatory changes within the disc, leading to structural breakdown and potential discogenic pain. Key mechanisms include extracellular matrix degradation, upregulation of inflammatory mediators, immune cell infiltration, and aberrant nerve and vascular ingrowth. However, not all cases of IVDD result in LBP, highlighting the need for further investigation into the cellular, molecular, and biomechanical factors contributing to symptom development. Current diagnostic tools and experimental models for studying discogenic LBP remain limited, impeding the development of targeted treatments. Existing therapies primarily focus on symptom management rather than addressing underlying disease mechanisms.